Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 5,392 shares at $243.23 ($1.3M) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Open-market sale of $1.3M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.51 | 158 | $37K | 2.9% |
| 2 | $238.33 | 123 | $29K | 2.2% |
| 3 | $239.18 | 127 | $30K | 2.3% |
| 4 | $240.32 | 284 | $68K | 5.2% |
| 5 | $240.32 | 284 | $68K | 5.2% |
| 6 | $241.51 | 461 |
| $111K |
| 8.5% |
| 7 | $241.51 | 461 | $111K | 8.5% |
| 8 | $242.44 | 1,093 | $265K | 20.3% |
| 9 | $242.44 | 1,093 | $265K | 20.3% |
| 10 | $243.23 | 440 | $107K | 8.2% |
| 11 | $243.23 | 440 | $107K | 8.2% |
| 12 | $244.11 | 214 | $52K | 4.0% |
| 13 | $244.11 | 214 | $52K | 4.0% |
| Total | $241.97 avg | 5,392 | $1.3M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |